LeMaitre Vascular (LMAT) will increase its quarterly dividend by 27.3 percent to $0.07 per share in the first quarter of 2018. The new dividend yield for LMAT is 0.8% and this marks the 7th consecutive year of dividend increases.

LeMaitre Vascular, Inc.  is a global provider of medical devices and human tissue cryopreservation services for the treatment of peripheral vascular disease. We develop, manufacture, and market vascular devices to address the needs of vascular surgeons. The company's portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and include the HYDRO Expandable LeMaitre Valvulotome, the XenoSure biologic patch, the Pruitt F3 Carotid Shunt and VascuTape Radiopaque Tape. The company's products are sold worldwide, primarily in the United States, Europe and, to a lesser extent, Asia and the Pacific Rim.